Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Bought by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. lifted its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 14.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 247,828 shares of the company’s stock after acquiring an additional 30,898 shares […]
More Stories
Wealth Enhancement Advisory Services LLC Trims Stock Position in iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV)
Wealth Enhancement Advisory Services LLC lowered its stake in shares of iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV – Free...
Lockheed Martin Co. (NYSE:LMT) Shares Bought by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its stake in shares of Lockheed Martin Co. (NYSE:LMT – Free Report) by 0.6%...
Wealth Enhancement Advisory Services LLC Purchases 680,584 Shares of Schwab Intermediate-Term U.S. Treasury ETF (NYSEARCA:SCHR)
Wealth Enhancement Advisory Services LLC raised its position in Schwab Intermediate-Term U.S. Treasury ETF (NYSEARCA:SCHR – Free Report) by 64.1%...
Devon Energy Co. (NYSE:DVN) Shares Sold by Hilltop National Bank
Hilltop National Bank lessened its stake in Devon Energy Co. (NYSE:DVN – Free Report) by 3.9% in the 4th quarter,...
The PNC Financial Services Group, Inc. (NYSE:PNC) Shares Sold by ST Germain D J Co. Inc.
ST Germain D J Co. Inc. reduced its position in The PNC Financial Services Group, Inc. (NYSE:PNC – Free Report)...
Alphabet (NASDAQ:GOOGL) Given New $225.00 Price Target at KeyCorp
Alphabet (NASDAQ:GOOGL – Free Report) had its target price lifted by KeyCorp from $215.00 to $225.00 in a report released...